title: [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
authors.affiliation: Servicio de Dermatología, Hospital Nuestra Señora del Prado, Talavera de la Reina, Toledo, España. icervigon@sescam.jccm.es
authors.forename: I
authors.initials: I
authors.lastname: Cervigón
authors.forename: A
authors.initials: A
authors.lastname: Palomo
authors.forename: L M
authors.initials: LM
authors.lastname: Torres-Iglesias
authors.forename: F
authors.initials: F
authors.lastname: Solano
authors.forename: A M
authors.initials: AM
authors.lastname: Zapata
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005871:Castleman Disease / Q000175:diagnosis; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D017254:Leukemic Infiltration / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D010160:Palate, Soft / Q000473:pathology*; D012010:Red-Cell Aplasia, Pure / Q000150:complications; D000069283:Rituximab; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018906:Antineoplastic Agents, Alkylating; D000069283:Rituximab; D003520:Cyclophosphamide; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine